As one of the important carriers of drugs, pharmaceutical packaging develops
with the development of the downstream pharmaceutical industry.
At present, in the case of the rapid development of the downstream pharmaceutical industry, China's pharmaceutical packaging industry has also ushered in opportunities, the market size is as high as 100 billion yuan, and the industry expects that the market size will exceed 150 billion
in 2023.
In this context, domestic leading enterprises that have been recognized as having opportunities have also attracted the attention
of investors.
Pharmaceutical packaging industry (Image source: Pharmaceutical Network)
In 2023, the size of China's pharmaceutical packaging market will exceed 150 billion
Under the background of the aging of the population, the continuous upgrading of consumption, and the increasing attention of residents to health, China's pharmaceutical market demand is expanding, which has brought growth momentum
to the upstream pharmaceutical packaging industry.
In recent years, the pharmaceutical packaging industry has also been supported by favorable policies, and industry standards have been continuously improved
.
In September 2022, China's first "Guidelines for the Reduction of Pharmaceutical Packaging Tablets and Capsules" group standard was officially released, which focuses on the collection of tablets and capsules, and puts forward relevant regulations
from the aspects of packaging void rate, number of packaging layers, material selection, medium packaging, and transport packaging.
With the release of standards, the industry generally believes that China's pharmaceutical packaging industry will open the road
of simplification.
With the increase of favorable policies and the rapid development of policy-supported pharmaceutical sub-industries such as biological drugs and traditional Chinese medicines in China, the development of the pharmaceutical packaging industry will be further accelerated, and the market scale is expected to continue to expand
.
According to data, the market size of China's pharmaceutical packaging industry in 2021 will be 135.
86 billion yuan, a year-on-year increase of 16%, and it is expected that the market size will reach 149.
4 billion yuan in 2022 and 150.
7 billion
yuan in 2023.
Domestic head enterprises attract the attention of investors
At present, in the context of the continuous expansion of the domestic pharmaceutical packaging market, the industry believes that domestic pharmaceutical packaging material companies are also expected to usher in development opportunities and accelerate the pace
of domestic substitution.
It is worth mentioning that at present, the number of domestic pharmaceutical packaging industry enterprises is large, the market concentration is low, the production enterprises of the layout of pharmaceutical packaging business are mostly small-scale enterprises, and there are relatively few enterprises that can adapt to the stability requirements of high-speed automatic packaging production lines of modern pharmaceutical enterprises.
Since 2023, some domestic leading pharmaceutical packaging companies have also attracted the attention
of investors.
For example, on January 9, Haishun New Materials said on the interactive platform that in recent years, the state has successively introduced a number of policies in the field of pharmaceutical packaging, providing broad market prospects and clear industry norms for the development of the pharmaceutical packaging industry, encouraging the development and innovation of pharmaceutical packaging material enterprises, and providing a good production and operation environment
for pharmaceutical packaging material enterprises.
On the same day, Haishun New Materials replied to investors that pharmaceutical packaging is an important part of the pharmaceutical industry, and pharmaceutical packaging material companies and downstream pharmaceutical companies promote each other and grow together, and are committed to promoting the high-quality development
of the health industry.
It is reported that the company intends to use 640 million yuan for pharmaceutical packaging business, involving "Global Printing Expansion and Green Packaging Intelligent Manufacturing Industrial Park (Phase I) Project", "Pharmaceutical Packaging Folding Carton Expansion and Intelligent Manufacturing Project", etc
.
Recently, some industry insiders expect that after the global printing project reaches production, the company's folding carton production capacity will expand, which will further expand the company's market share in the future
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
